Expression of SOX9 in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Expression of SOX9 in Intraductal Papillary Mucinous Neoplasms of the Pancreas
复制标题
DOI:
10.1097/mpa.0b013e3182a70b2f
复制
发表时间:
2014-01
期刊:
影响因子:
2.9
通讯作者:
Fanbin Meng;K. Takaori;Tatsuo Ito;T. Masui;Michiya Kawaguchi;Y. Kawaguchi;S. Uemoto
中科院分区:
文献类型:
--
作者:
Fanbin Meng;K. Takaori;Tatsuo Ito;T. Masui;Michiya Kawaguchi;Y. Kawaguchi;S. Uemoto
Objectives SRY (sex determining region Y) box 9 (SOX9) plays a key role in the embryologic development, differentiation, and maintenance of organs in the pancreas as well as progression of several kinds of tumors. The aim of the present study was to evaluate the expression and potential role of SOX9 in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Methods The authors selected 27 pathological tissues from 19 IPMN cases to assess the expression of SOX9 by means of immunohistochemistry and analyzed the expression pattern of SOX9 with 78 lesions obtained from these tissues stained by SOX9. Results SOX9 was expressed in the normal pancreas, IPMN, and pancreatic ductal adenocarcinoma. SOX9-positive cells were confined to the lower portions of the papillary structures of IPMN. However, SOX9 was expressed in the entire epithelium once the neoplasms advanced to high-grade dysplasia and invasive carcinoma. The expression pattern of SOX9 was similar to that of CD44 in the normal pancreas and IPMN. Double staining of SOX9 and CD44 detected colocalization of SOX9 and CD44 in IPMN. Conclusions Changes in the SOX9 expression pattern may be involved in the mechanisms of the malignant progression of IPMN.